Dr. Gurwitz, the Executive Director of the Meyers Primary Care Institute, is a nationally recognized expert in geriatric medicine and the safe use of medications in elderly patients. He is the Dr. John Meyers Professor of Primary Care Medicine at the University of Massachusetts Medical School, where he is also chief of the Section for Health Services Research in the Division of General Medicine and Primary Care, and Professor of Medicine and Family Medicine/Community Health. A 1983 graduate of the University of Massachusetts Medical School, Dr. Gurwitz completed his residency in internal medicine at the University of Massachusetts Hospital in 1986. He completed a fellowship in geriatric medicine at Harvard Medical School and remained on the faculty at Harvard until returning to Worcester to assume his current position as the first executive director of the Institute, in 1996.
Dr. Gurwitz has published numerous original articles, reviews, commentaries and book chapters on the optimal use of drug therapy in elderly patients. He is a fellow of the American College of Physicians, the American Geriatrics Society, and the Gerontological Society of America.
|1.||Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16. |
|2.||Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, DeBellis K, Moldoff J, Verzier N. The safety of warfarin therapy in the nursing home setting. Am J Med 2007;120:539-44. |
Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. Gurwitz JH, Field TS, Rochon P, Judge J, Harrold LR, Bell CM, Lee M, White K, LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Baril JL, Reed G, Bates DW.J Am Geriatr Soc. 2008 Dec;56:2225-33.
|4.||Chen Y, Briesacher BA, Field TS, Tjia J, Lau DT, Gurwitz JH. Unexplained variation across U.S. nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010;170:89-95.|
|5.||Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, ReedG, Doherty P, Spenard A, Gurwitz JH. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach. Am J Med 2011; 124:179.e1-7. |